Our experience spans from small molecules to complex therapeutic proteins like monoclonal antibodies, vaccines and blood factors. Accelsiors is a recognized expert CRO in the clinical development of Biosimilars and Biobetters but we have also great experience with various innovative biologics.
Accelsiors has designed, managed, and monitored several Phase I, Phase II, and Phase III trials with involvement of complex clinical, PK/PD, immunological, and imaging assessments. Our specialty is complex early clinical trials where we often act as rescue CRO for trials other CROs were not able to manage. Some of these compounds we carried all the way from Phase I to Phase III.
Even though mid-sized in terms of number of employees, we are true global expert leaders in several niche indications in which we also managed other global CROs. This expertise is based on understanding of the finesse of the diagnostics, regulatory requirementfor outcome and safety measures and intimate collaboration with clinical opinion leaders. There is probably no other CRO which can boast more experience and expertise in conduct of clinical trials in:
- Growth hormone deficiency and acromegaly
- Multiple sclerosis
- Cystic fibrosis
We also conduct early phase clinical trials in special patients populations like
- Pediatric patients of each age groups
- Patients with compensated and decompensated liver cirrhosis
- Both adult and pediatric patients with cystic fibrosis
- Oncology patients
Accelsiors has been working in many indications however our experience and expertise is significant in the following fields:
- Endocrinology
- Neurology
- Respiratory disorders
- Oncology
- Dermatology
- Cardiology
- Infectious disease
For further details please do not hesitate to contact us or download our company brochure and full company presentation.
